Secure Port IV Hautkleber

Der einzige Cyanoacrylat-Klebstoff, der zur Fixierung und Sicherung des vaskulären Zugangs (Midline, PICC, ZVK) entwickelt wurde

Secure Port IV Hautkleber
Secure Port IV Hautkleber

Einzigartige Zusammensetzung (80% 2-Oktyl-CA und 20% n-Butyl-CA) ermöglicht Flexibilität und eine schnelle Trocknung.  


Zur Tabelle
Auswahl zurücksetzen
Artikelbezeichnung

Bitte wählen Sie eine Variante
Haben Sie Fragen?
Wir sind persönlich für Sie erreichbar
Benötigen Sie weitere Infos?
Formular
PDF
Drucken

WSK-10414

SecurePortIVTM Hautkleber

Der einzige Cyanoacrylat-Klebstoff, der zur Fixierung und Sicherung des vaskulären Zugangs (Midline, PICC, ZVK) entwickelt wurde

Die Verwendung von Cyanoacrylat-Kleber wird in internationalen Leitlinien empfohlen24-27 


Literatur: 

 

[1] iData 2020.

[2] iData 2023 Report - 2025 Estimates.

[3] Carr et al. From insertion to removal: A multicenter survival analysis of an admitted cohort with peripheral intravenous catheters inserted in the emergency department. Infection Control & Hospital Epidemiology (2018)

[4] Anderson et al. Midline Catheters. The Middle Ground of Intravenous Therapy Administration. J Infus Nurs. 2004 Sep-Oct 27(5):313-21.

[5] Maki et al. The Risk of Bloodstream Infection in Adults With Different Intravascular Devices: A Systematic Review of 200 Published Prospective Studies. Mayo Clin Proc. 2006:81(9):1159-1171.

[6] Al Raiy et al. Peripherally inserted central venous catheters in the acute care setting: A safe alternative to high-risk short-term central venous catheters. Am J Infect Control (2010) 38:149-53.

[7] Chopra et al. Bloodstream Infection, Venous Thrombosis, and Peripherally Inserted Central Catheters: Reappraising the Evidence. The American Journal of Medicine (2012) 125, 733-741.

[8] Grau et al. Complications with peripherally inserted central catheters (PICCs) used in hospitalized patients and outpatients: a prospective cohort study. Antimicrobial Resistance and Infection Control (2017) 6:18.

[9] Leroyer et al. Prospective follow-up of complications related to peripherally inserted central catheters. Médecine et maladies infectieuses 43 (2013) 350-355.

[10] Parienti et al. Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med (2015) 373:1220-9.

[11] Tacconelli et al. Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates. Journal of Hospital Infection (2009) 72,97-103

[12] Van der Kooi et al. Prevention of hospital infections by intervention and training (PROHIBIT): results of a pan-European cluster-randomized multicentre study to reduce central venous catheterrelated bloodstream infections. Intensive Care Med (2017).

[13] Van Rens MFPT, Bayoumi MAA, van de Hoogen A, Francia ALV, Cabanillas IJ, van Loon FHJ, Spencer TR. The ABBA project (Assess Better Before Access): A retrospective cohort study of neonatal intravascular device outcomes

[14] Fiammetta Piersigilli et al Cyanoacrylate glue as part of a new bundle to decrease neonatal PICC-related complications. European Journal of Pediatrics. 2023.

[15] Rickard et al.A 4-arm randomized controlled pilot trial of innovative solutions for jugular central venous access device securement in 221 cardiac surgical patients. J Crit Care. 2016

[16] Kleidon et al. A pilot randomised controlled trial of novel dressing and securement techniques in 101 pediatric patients. J Vasc Interv Radiol. 2017.

[17] Ullman et al. Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial. BMC Cancer. 2017.

[18] Fiammetta Piersigilli et al,: How to Minimize Central Line-Associated Bloodstream Infections in a Neonatal Intensive Care Unit: A Quality Improvement Intervention Based on Retrospective Analysis and the Adoption of an Evidence-Based Bundle"

[19] Webber JLR. Maningo-Salinas MJ. "Sticking It to Them"-Reducing Migration of Peripherally Inserted Central Catheters. J Vascular Access. 2020 Spring:25(1):10-15

[20] Zhang et al. Experimental study on the hemostatic effect of cyanoacrylate intended for catheter securement. JVA. 2018.

[21] 2022 National Teaching Institute Evidence-Based Solutions Abstracts. Crit Care Nurse. Apr 1 2022:42(2):e10-236.

[22] Prince et al. Antibacterial effect and proposed mechanism of action of a topical surgical adhesive. AJIC 2017.

[23] Van Rens et al. (2021)

[24] AVATAR Organization

[25] AVA 2021 (Association for Vascular Access)

[26] INS 2024 (Infusion Nursing Society) Standards of Practice

[27] NANN 2022.

Artikelbezeichnung Art.-Nr. PZN Menge je VE
Secure Port IV Hautkleber SP-015V50 19530491 50
Weitere Produkte